true

Licensing opportunities

Cutting-edge technologies and novel solutions for patients that emerge from research labs and clinical activities
style
palette-deep-blue
showJumplinks
false
At Mass General Brigham Innovation, we manage hundreds of cutting-edge technologies and novel solutions for patients that emerge from research labs and clinical activities across our hospital system. Our Business Development & Licensing team selected just a few of these inventions to showcase the scope of the Mass General Brigham Innovation portfolio. Learn about the featured technology’s background, mechanism, stage of development, investigators, intellectual property, and commercial proposition.
These inventions are only a small selection of the licensing opportunities that are available. If you’re interested in learning more about a specific technology, please contact the listed Business Development & Licensing Manager.

Extracorporeal Blood Phototherapy to Remove Carbon Monoxide (CO) From the Blood of a CO-poisoned Individual

/content/research-xwalk/en/researchers-and-collaborators/innovation/licensing-opportunities/extracorporeal-blood-phototherapy-remove-carbon-monoxide

Glycopatch Bioadhesive Membrane

/content/research-xwalk/en/researchers-and-collaborators/innovation/licensing-opportunities/glycopatch-bioadhesive-membrane

Method for Ultra High Throughput Transfection by Viscoelastic Cell Stretching dhesive Membrane

/content/research-xwalk/en/researchers-and-collaborators/innovation/licensing-opportunities/ultra-high-throughput-transfection-viscoelastic-cell

Novel MicroRNAs Targeting Hepatic Stellate Cells in Treatment of Fibrosis in Progressive Liver Diseases

/content/research-xwalk/en/researchers-and-collaborators/innovation/licensing-opportunities/micro-rnas-fibrosis-treatment

Novel Polyethylene Implant Material to Locally Release Therapeutic Agents for Pain and Infection Control

/content/research-xwalk/en/researchers-and-collaborators/innovation/licensing-opportunities/polyethylene-implant-for-joint-pain-infection

Photochemical Tissue Passivation Prevents Contracture of Full-Thickness Wounds

/content/research-xwalk/en/researchers-and-collaborators/innovation/licensing-opportunities/photochemical-tissue-passivation

Use of Small Molecule Inhibitors to KLF10 for Modulation of T Regulatory Cells and Cancer Immunotherapy

/content/research-xwalk/en/researchers-and-collaborators/innovation/licensing-opportunities/small-molecule-inhibitors-cancer-immunotherapy

CD70 Targeted Chimeric Antigen Receptor (CAR) T-Cells for Acute Myeloid Leukemia (AML)

/content/research-xwalk/en/researchers-and-collaborators/innovation/licensing-opportunities/car-t-cell-therapy-aml

Therapeutic Properties of Obtusaquinone and its Derivatives

/content/research-xwalk/en/researchers-and-collaborators/innovation/licensing-opportunities/obtusaquinone-cancer-treatment

Sprayable, Immune Cell Targeting, and Squaraine NIR Fluorophores for Image-guided Cancer Surgery

/content/research-xwalk/en/researchers-and-collaborators/innovation/licensing-opportunities/sprayable-immune-cell-squaraine-nir-fluorophores-image-guided-surgery

style
palette-white
showJumplinks
true

Business Development & Licensing Manager

If you’re interested in learning more about the other opportunities we have available, please reach out.
We would be happy to speak with you.
tertiary
email
Email: licensing@partners.org
licensing@partners.org
style
palette-light-teal
showJumplinks
true